Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project

INTRODUCTION: Little is known about the comparative effects of sodium glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP1-RA), or dipeptidyl peptidase-4 inhibitors (DPP-4i) on the risk of acute kidney injury (AKI) in routine care, which may differ from the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkas, Jim, Bosi, Alessandro, Sjölander, Arvid, Barany, Peter, Elinder, Carl-Gustaf, Fu, Edouard L., Carrero, Juan Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090010/
https://www.ncbi.nlm.nih.gov/pubmed/36459371
http://dx.doi.org/10.1007/s40620-022-01505-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090010/
https://www.ncbi.nlm.nih.gov/pubmed/36459371
http://dx.doi.org/10.1007/s40620-022-01505-8

Ejemplares similares